CoChat

Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

STUDY QUESTION: Does intrauterine biosynthesis of estrogen play an important role in early pregnancy by altering the function of uterine natural killer (uNK) cells? SUMMARY ANSWER: Estrogens directly regulate the function of human uNK cells by increasing uNK cell migration and secretion of uNK cell-derived chemokine (C-C motif) ligand 2 (CCL2) that critically facilitates uNK-mediated angiogenesis. WHAT IS KNOWN ALREADY: uNK cells are a phenotypically distinct population of tissue-resident immune cells that regulate vascular remodelling within the endometrium and decidua. Recently we discovered that decidualisation of human endometrial stromal cells results in the generation of an estrogen-rich microenvironment in areas of decidualised endometrium. We hypothesize that intrauterine biosynthesis of estrogens plays an important role in early pregnancy by altering the function of uNK cells. STUDY DESIGN, SIZE, DURATION: This laboratory-based study used primary human uNK cells which were isolated from first trimester human decidua (n = 32). PARTICIPANTS/MATERIALS, SETTING, METHODS: Primary uNK cells were isolated from first trimester human decidua using magnetic cell sorting. The impact of estrogens on uNK cell function was assessed. Isolated uNK cells were treated with estrone (E1, 10(-8) M) or estradiol (E2, 10(-8) M) alone or in combination with the anti-estrogen ICI 182 780 (ICI, 10(-6) M). uNK cell motility was assessed by transwell migration assay and time-lapse microscopy. Expression of chemokine receptors was assessed by quantitative PCR (qPCR) and immunohistochemistry, and angiogenic factors were assessed by qPCR and cytokine array. Concentrations of CCL2 in supernatants were measured by enzyme-linked immunosorbent assay. Angiogenesis was assessed in a human endometrial endothelial cell network formation assay. MAIN RESULTS AND THE ROLE OF CHANCE: Treatment with either E1 or E2 increased uNK cell migration (P = 0.0092 and P = 0.0063, respectively) compared with control. Co-administration of the anti-estrogen ICI blocked the effects of E1 and E2 on cell migration. Concentrations of C-X-C chemokine receptor type 4 (CXCR4) mRNA in uNK cells were increased by E2 treatment. The network formation assay revealed that conditioned media from uNK cells treated with E2 significantly increased human endometrial endothelial cell (HEEC) angiogenesis (P = 0.0029 versus control). Analysis of media from uNK cells treated with E2 using an antibody array identified CCL2 as the most abundant cytokine. Validation assays confirmed concentrations of CCL2 mRNA and protein were increased by E2 in uNK cells (P < 0.05 versus controls). Compared with the control, recombinant human CCL2 was found to increase HEEC network formation (P < 0.05) and neutralization of CCL2 in uNK conditioned media significantly decreased E2-dependent uNK-mediated network formation (P = 0.0006). LIMITATIONS, REASONS FOR CAUTION: Our results are based on in vitro responses of primary human cells and we cannot be certain that similar mechanisms occur in vivo in humans. Primary human uNK cells were isolated from first trimester decidua at a range of gestations (8-12 weeks), which may be a source of variation. Primary human uNK cells from non-pregnant endometrium were not assessed and therefore the responses of uNK cells to E2 treatment described in this study may be distinct to uNK cells from first trimester decidua. WIDER IMPLICATIONS OF THE FINDINGS: E2 is an essential regulator of reproductive competence. This study demonstrates a critical role for E2 in regulating cellular cross-talk within the endometrium during early pregnancy. We provide the first evidence that E2 directly regulates the function of human uNK cells by altering uNK cell migration and the secretion of uNK-derived angiogenic factors. We describe a novel mechanism of estrogen-dependent secretion of CCL2 which critically mediates uNK-dependent endometrial angiogenesis. Dysregulation of uNK cell function has been implicated in the aetiology of early implantation disorders and disorders of pregnancy. These novel findings provide unique insight into the regulation of uNK cell activity during the establishment of pregnancy in women and highlight key processes which may be targeted in future therapeutic strategies. STUDY FUNDING/COMPETING INTERESTS: Studies undertaken in the authors' laboratory were supported by MRC Programme Grant G1100356/1 to P.T.K.S. The authors have no conflicts of interest to disclose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dev067

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Estrogens promote uNK cell migration and chemokinesis. Uterine natural killer (uNK) cells were treated in duplicate with estrone (E1) or estradiol (E2) alone or in combination with the anti-estrogen ICI 182, 780 (ICI). Relative fold change responses were compared with vehicle control (dimethyl sulfoxide, DMSO). (A) E1 significantly increased uNK cell migration by ∼1.8-fold (n = 6, One-sample t-test, P = 0.0092), co-administration of ICI blocked E1-mediated increased migration (Mann–Whitney test, P = 0.0022). (B) E2 significantly increased uNK cell migration 2.6-fold (n = 6, One-sample t-test, P = 0.0063), co-administration of ICI blocked E2-mediated increased migration (Mann–Whitney test, P = 0.0260). uNK cell motility in cells treated with vehicle control (DMSO, n = 30 cells) or E2 (n = 30 cells) was assessed using time-lapse video microscopy (Supplementary Videos S1 and S2). (C) E2 treatment significantly increased uNK cell velocity (µm/min) compared with vehicle control (Student's t-test, P = 0.0016). (D) E2 treatment significantly increased the accumulated uNK cell distance (µm) compared with vehicle control (Student's t-test, P = 0.0016). The expression of chemokine receptors in uNK cells in response to E2 was assessed by quantitative PCR (qPCR); fold change compared with vehicle control was determined. (E) E2 tended to increase concentrations of mRNAs encoding C-X-C chemokine receptor type 4 (CXCR4) (n = 5, One-sample t-test, P = 0.0585). (F) IL15RA mRNA was unchanged. The expression of the uNK chemoattractant C-X-C motif chemokine 12 (CXCL12) and its receptor CXCR4 were assessed in first trimester human decidua by immunohistochemistry. (G) Positive staining for CXCR4 (green) was detected in CD56-positive uNK cells (red staining). (H) CXCL12 did not co-localize with CD56-positive uNK cells (asterisks); however, positive staining was detected in decidualised stromal cells (arrows) and epithelial cells (green staining) in decidua. Nuclear counterstain DAPI (blue staining). Scale bar 50 µm. *P < 0.05, **P < 0.01.
Figure 1 Estrogens promote uNK cell migration and chemokinesis. Uterine natural killer (uNK) cells were treated in duplicate with estrone (E1) or estradiol (E2) alone or in combination with the anti-estrogen ICI 182, 780 (ICI). Relative fold change responses were compared with vehicle control (dimethyl sulfoxide, DMSO). (A) E1 significantly increased uNK cell migration by ∼1.8-fold (n = 6, One-sample t-test, P = 0.0092), co-administration of ICI blocked E1-mediated increased migration (Mann–Whitney test, P = 0.0022). (B) E2 significantly increased uNK cell migration 2.6-fold (n = 6, One-sample t-test, P = 0.0063), co-administration of ICI blocked E2-mediated increased migration (Mann–Whitney test, P = 0.0260). uNK cell motility in cells treated with vehicle control (DMSO, n = 30 cells) or E2 (n = 30 cells) was assessed using time-lapse video microscopy (Supplementary Videos S1 and S2). (C) E2 treatment significantly increased uNK cell velocity (µm/min) compared with vehicle control (Student's t-test, P = 0.0016). (D) E2 treatment significantly increased the accumulated uNK cell distance (µm) compared with vehicle control (Student's t-test, P = 0.0016). The expression of chemokine receptors in uNK cells in response to E2 was assessed by quantitative PCR (qPCR); fold change compared with vehicle control was determined. (E) E2 tended to increase concentrations of mRNAs encoding C-X-C chemokine receptor type 4 (CXCR4) (n = 5, One-sample t-test, P = 0.0585). (F) IL15RA mRNA was unchanged. The expression of the uNK chemoattractant C-X-C motif chemokine 12 (CXCL12) and its receptor CXCR4 were assessed in first trimester human decidua by immunohistochemistry. (G) Positive staining for CXCR4 (green) was detected in CD56-positive uNK cells (red staining). (H) CXCL12 did not co-localize with CD56-positive uNK cells (asterisks); however, positive staining was detected in decidualised stromal cells (arrows) and epithelial cells (green staining) in decidua. Nuclear counterstain DAPI (blue staining). Scale bar 50 µm. *P < 0.05, **P < 0.01.CC BY · PubMed Central
Figure 2 Estradiol promotes uNK-mediated network formation in endometrial endothelial cells via uNK estrogen receptor. Human endometrial endothelial cell (HEEC) network formation was assessed in response to uNK conditioned media (CM). Network formation was quantified as fold change relative to vehicle control. (A) CM from uNK cells treated with E2 significantly increased network formation in HEECs (n = 10, One-sample t-test, P = 0.0029). (B) Blocking of HEEC estrogen receptor (ER)β with ICI did not affect uNK-mediated increased network formation (n/s: not significant, n = 3, Mann–Whitney test). (C) CM from uNK cells treated with ICI or uNK cells treated with E2 in combination with ICI (E2+ICI) had no significant impact on network formation. CM from uNK cells treated with E2 significantly increased network formation relative to all treatments including endothelial basal growth media (EBM, P = 0.002). CM from uNK cells co-treated with E2 and ICI significantly decreased network formation compared with CM from uNK cells treated with E2 alone (n = 7, Mann–Whitney test, P = 0.0136). *P < 0.05, **P < 0.01. Images were captured at ×5 magnification using the Axiovert 200 Inverted Fluorescent Microscope.
Figure 2 Estradiol promotes uNK-mediated network formation in endometrial endothelial cells via uNK estrogen receptor. Human endometrial endothelial cell (HEEC) network formation was assessed in response to uNK conditioned media (CM). Network formation was quantified as fold change relative to vehicle control. (A) CM from uNK cells treated with E2 significantly increased network formation in HEECs (n = 10, One-sample t-test, P = 0.0029). (B) Blocking of HEEC estrogen receptor (ER)β with ICI did not affect uNK-mediated increased network formation (n/s: not significant, n = 3, Mann–Whitney test). (C) CM from uNK cells treated with ICI or uNK cells treated with E2 in combination with ICI (E2+ICI) had no significant impact on network formation. CM from uNK cells treated with E2 significantly increased network formation relative to all treatments including endothelial basal growth media (EBM, P = 0.002). CM from uNK cells co-treated with E2 and ICI significantly decreased network formation compared with CM from uNK cells treated with E2 alone (n = 7, Mann–Whitney test, P = 0.0136). *P < 0.05, **P < 0.01. Images were captured at ×5 magnification using the Axiovert 200 Inverted Fluorescent Microscope.CC BY · PubMed Central
Figure 3 E2-dependent regulation of angiogenic factors in uNK cells. The top two targets identified by PCR array; chemokine (C-C motif) ligand 2 (CCL2) and interferon gamma (IFNγ), were selected for follow-up validation by qPCR. Fold change compared with vehicle control was determined. (A) E2 significantly increased expression of CCL2 mRNA (n = 10, One-sample t-test, P = 0.0394) compared with control (DMSO). (B) Concentrations of mRNAs encoding IFNG tended to be increased by E2 treatment (P = 0.0565, n = 9). (C) Cytokines/growth factors in CM from uNK cells treated with E2 were assessed by cytokine array; levels of IFNγ were low/undetectable, CCL2 was abundant. (D) Concentrations of CCL2 were assessed by Milliplex bead assay. Concentrations of CCL2 were significantly increased in CM from uNK cells treated with E2 (n = 5, One-sample t-test, P = 0.0408 versus control). *P < 0.05, **P < 0.01.
Figure 3 E2-dependent regulation of angiogenic factors in uNK cells. The top two targets identified by PCR array; chemokine (C-C motif) ligand 2 (CCL2) and interferon gamma (IFNγ), were selected for follow-up validation by qPCR. Fold change compared with vehicle control was determined. (A) E2 significantly increased expression of CCL2 mRNA (n = 10, One-sample t-test, P = 0.0394) compared with control (DMSO). (B) Concentrations of mRNAs encoding IFNG tended to be increased by E2 treatment (P = 0.0565, n = 9). (C) Cytokines/growth factors in CM from uNK cells treated with E2 were assessed by cytokine array; levels of IFNγ were low/undetectable, CCL2 was abundant. (D) Concentrations of CCL2 were assessed by Milliplex bead assay. Concentrations of CCL2 were significantly increased in CM from uNK cells treated with E2 (n = 5, One-sample t-test, P = 0.0408 versus control). *P < 0.05, **P < 0.01.CC BY · PubMed Central
Figure 4 E2-dependent secretion of CCL2 regulates uNK-mediated angiogenesis. HEEC network formation was assessed in response to recombinant human CCL2 (rCCL2). (A) Network formation was significantly increased in response to 0.1 ng/ml rCCL2 (n = 4, One-sample t-test, P = 0.0348) and maximal in response to 0.5 ng/ml (n = 4, One-sample t-test, P = 0.047). (B) HEEC were incubated with 0.5 ng/ml rCCL2 and increasing concentrations of a monoclonal antibody to CCL2 (mAb-CCL2). HEEC network formation was assessed relative to 0 µg/ml mAb-CCL2. Neutralization of rCCL2 with mAb-CCL2 significantly inhibited HEEC network formation at concentrations of 0.1 µg/ml (P = 0.0174) and greater (n = 4, One-sample t-test, 0.5 µg/ml; P = 0.0026, 1 and 5 µg/ml; P = 0.0005). (C) uNK-E2 CM was incubated with 0.5 µg/ml mAb-CCL2 and HEEC network formation was assessed relative to control uNK CM (DMSO). Neutralization of CCL2 significantly reduced HEEC network formation (n = 8, One-sample t-test, P = 0.0069) and reversed uNK-E2-mediated increased network formation (n = 8, Mann–Whitney, P = 0.0006). *P < 0.05, **P < 0.01, ***P < 0.001. Images were captured at ×5 magnification using the Axiovert 200 Inverted Fluorescent Microscope.
Figure 4 E2-dependent secretion of CCL2 regulates uNK-mediated angiogenesis. HEEC network formation was assessed in response to recombinant human CCL2 (rCCL2). (A) Network formation was significantly increased in response to 0.1 ng/ml rCCL2 (n = 4, One-sample t-test, P = 0.0348) and maximal in response to 0.5 ng/ml (n = 4, One-sample t-test, P = 0.047). (B) HEEC were incubated with 0.5 ng/ml rCCL2 and increasing concentrations of a monoclonal antibody to CCL2 (mAb-CCL2). HEEC network formation was assessed relative to 0 µg/ml mAb-CCL2. Neutralization of rCCL2 with mAb-CCL2 significantly inhibited HEEC network formation at concentrations of 0.1 µg/ml (P = 0.0174) and greater (n = 4, One-sample t-test, 0.5 µg/ml; P = 0.0026, 1 and 5 µg/ml; P = 0.0005). (C) uNK-E2 CM was incubated with 0.5 µg/ml mAb-CCL2 and HEEC network formation was assessed relative to control uNK CM (DMSO). Neutralization of CCL2 significantly reduced HEEC network formation (n = 8, One-sample t-test, P = 0.0069) and reversed uNK-E2-mediated increased network formation (n = 8, Mann–Whitney, P = 0.0006). *P < 0.05, **P < 0.01, ***P < 0.001. Images were captured at ×5 magnification using the Axiovert 200 Inverted Fluorescent Microscope.CC BY · PubMed Central
Figure 5 Summary: Regulation of endometrial function in early pregnancy. Stromal cells and uNK cells interact with endometrial arterioles to promote vascular remodelling. 1. In the decidua, stromal cells secrete estrogens such as E1 and E2. 2. E2 increases uNK cell motility and migration both directly and by increasing the expression of the chemokine receptor CXCR4. This action of E2 may promote localization/recruitment of uNK cells in the perivascular niche. 3. E2 acts directly on uNK cells to promote secretion of pro-angiogenic factors including CCL2. 4. ER-dependent secretion of CCL2 promotes endothelial cell angiogenesis and modulation of vascular function.
Figure 5 Summary: Regulation of endometrial function in early pregnancy. Stromal cells and uNK cells interact with endometrial arterioles to promote vascular remodelling. 1. In the decidua, stromal cells secrete estrogens such as E1 and E2. 2. E2 increases uNK cell motility and migration both directly and by increasing the expression of the chemokine receptor CXCR4. This action of E2 may promote localization/recruitment of uNK cells in the perivascular niche. 3. E2 acts directly on uNK cells to promote secretion of pro-angiogenic factors including CCL2. 4. ER-dependent secretion of CCL2 promotes endothelial cell angiogenesis and modulation of vascular function.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 108

Metadata

Authors
Gibson, D. A., Greaves, E., Critchley, H. O. D., & Saunders, P. T. K.
Affiliations
  • Centre for Inflammation Research (GB)
  • MRC Centre for Reproductive Health (GB)
Corresponding author
Saunders, P.T.K.
Venue
Human Reproduction
Published
2015-03-27
Volume
30
Issue
6
Pages
1290-1301
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2046480624
Cited by
108
References
53
Citations by year
2026: 8 · 2025: 11 · 2024: 4 · 2023: 8 · 2022: 18 · 2021: 14 · 2020: 10 · 2019: 9 · 2018: 6 · 2017: 12 · 2016: 8
FWCI
4.27
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Human Reproduction (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • U.S. Public Health Service (G1100356)
  • Medical Research Council (G1100356/1)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Keywords
uterine natural killer cells, estrogen, estradiol, estrone, MCP-1, vascular remodeling, angiogenesis, CXCR4, CXCR3, CXCR6, chemokine receptors, decidualization, endometrium, decidua, early pregnancy, fulvestrant, antiestrogens
MeSH terms
Cell Movement, Endometrium, Estrogens, Female, Gene Expression Regulation, Humans, Killer Cells, Natural, Pregnancy, Pregnancy Trimester, First, Uterus, Cytokines, Neovascularization, Physiologic, Chemokines, C, Vascular Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.